OncLive TV

OncLive® TV is an editorial video program featuring one-on-one live and/or virtual interviews with key opinion leaders in the oncology field for their expert insight on breaking news, regulatory updates, practice-changing data presented at medical meetings, and other pivotal topics in a cancer specialty, including breast cancer, lung cancer, genitourinary cancers, gastrointestinal cancers, gynecologic cancers, and hematologic cancers.

Dr. Chase on the Importance of Genetic Testing for BRCA Mutations in Ovarian Cancer

August 12th 2021

Dana Chase, MD, FACOG, gynecologic oncologist, discusses the importance of utilizing genetic testing for BRCA mutations in ovarian cancer.

Dr. Extermann on the Utility of Trastuzumab Monotherapy in HER2+ Breast Cancer

August 11th 2021

Martine Extermann, MD, PhD, discusses the utility of single-agent trastuzumab in HER2-positive breast cancer.

Dr. Slovin on Considerations for Treatment Selection in Nonmetastatic CRPC

August 11th 2021

Susan F. Slovin, MD, PhD, discusses considerations for treatment selection in nonmetastatic castration-resistant prostate cancer.

Dr. Thompson on the Evolving Role of MRD Testing in CLL

August 11th 2021

Meghan Thompson, MD, discusses the evolving role of minimal residual disease testing in chronic lymphocytic leukemia.

Dr. Kahl on the Emergence of Antibody-Drug Conjugates in Lymphoma

August 11th 2021

Brad S. Kahl, MD, discusses the emergence of antibody-drug conjugates in lymphoma.

Dr. Vose on Future Research Efforts With CAR T-Cell Therapy in Lymphoma

August 11th 2021

Julie M. Vose, MD, MBA, discusses future research efforts with CAR T-cell therapy in lymphoma.

Dr. Moskowitz on the Challenges of Intensifying Treatment in Hodgkin Lymphoma

August 11th 2021

Alison J. Moskowitz, MD, discusses the challenges of intensifying treatment in Hodgkin lymphoma.

Dr. Ansell on Incorporating Immunotherapies Beyond CAR T-Cell Therapy in NHL

August 11th 2021

Stephen M. Ansell, MD, PhD, discusses incorporating immunotherapies beyond CAR T-cell therapy in non-Hodgkin lymphoma.

Dr. Roeker on the Rationale for BTK/Venetoclax Combos in CLL

August 10th 2021

Lindsey Roeker, MD, discusses the rationale for combining venetoclax with BTK inhibitors for use in patients with chronic lymphocytic leukemia.

Dr. Danila on Considerations for Treatment Selection in Nonmetastatic CRPC

August 10th 2021

Daniel C. Danila, MD, discusses factors to consider when selecting a treatment option for patients with nonmetastatic castration-resistant prostate cancer.

Dr. Harris on the Adoption of Immunotherapy in Advanced HCC

August 10th 2021

William P. Harris, MD, discusses the adoption of immunotherapy in advanced hepatocellular carcinoma.

Dr. Lee on the Evolving Treatment Paradigm in Relapsed/Refractory Multiple Myeloma

August 10th 2021

Hans Lee, MD, discusses the evolving treatment paradigm in relapsed/refractory multiple myeloma.

Dr. Jones on the Importance of Immune Checkpoint Inhibitors in CRC

August 10th 2021

Jeremy C. Jones, MD, discusses key lessons learned from the phase 3 KEYNOTE-177 trial.

Dr. Willmott on the Importance of Genetic Testing in Ovarian Cancer

August 9th 2021

Lyndsay Willmott, MD, discusses the importance of genetic testing in ovarian cancer.

Dr. Labaki on Disparities in Mammography Screenings During the COVID-19 Pandemic

August 9th 2021

Chris Labaki, MD, discusses racial disparities with regard to mammography screenings during the COVID-19 pandemic.

Dr. Trinh on the Recovery of Cancer Screening Tests Following First COVID-19 Pandemic Peak

August 9th 2021

Quoc-Dien Trinh, MD, discusses findings from a study examining the temporal changes in cancer tests and diagnoses in a large healthcare system in the United States during the COVID-19 pandemic.

Dr. Danila on the Integration of Advanced Imaging in Prostate Cancer

August 9th 2021

Daniel C. Danila, MD, discusses the integration of advanced imaging in prostate cancer.

Dr. Lentzsch on the Utility of Cellular Therapies in Multiple Myeloma

August 9th 2021

Suzanne Lentzsch, MD, discusses the utility of cellular therapies in multiple myeloma.

Dr. Mikhael on Treatment Selection for Early Relapse in Multiple Myeloma

August 9th 2021

Joseph Mikhael, MD, discusses treatment selection for early relapse in multiple myeloma.

Dr. Wang on the Rationale for Viral Hepatitis Screening to Prevent HCC

August 9th 2021

Su H. Wang, MD, MPH, discusses the rationale for the integration of viral hepatitis screening and care in a hospital system as the first steps for preventing liver cancers like hepatocellular carcinoma.